NLM Digital Collections

Search

Start Over Collections Health Policy and Services Research ✖Remove constraint Collections: Health Policy and Services Research Subjects Drug and Narcotic Control ✖Remove constraint Subjects: Drug and Narcotic Control Subjects United States ✖Remove constraint Subjects: United States Copyright Public domain ✖Remove constraint Copyright: Public domain

1. Memory supplements: clarifying FDA and FTC roles could strengthen oversight and enhance consumer awareness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Dietary Supplements
Drug and Narcotic Control
Government Regulation
Marketing of Health Services
Memory -- drug effects
Memory Disorders -- drug therapy
Advertising as Topic
Commerce
Internet
Humans
United States
United States. Federal Trade Commission.
United States. Food and Drug Administration.

2. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Drug and Narcotic Control
Prescription Drug Diversion -- prevention & control
Prescription Drug Misuse -- prevention & control
Voluntary Programs
Government Programs
Pharmacies
Prescription Drugs
State Government
Humans
United States
United States. Drug Enforcement Administration.

3. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

4. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, October 2020
Subject(s):
Drug Industry
Drug and Narcotic Control
Pharmaceutical Preparations
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

6. E2B(R3) electronic transmission of Individual Case Safety Reports (ICSRs) implementation guide: data elements and message specification

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2022
Subject(s):
Adverse Drug Reaction Reporting Systems
Drug and Narcotic Control
Electronic Mail
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration